Literature DB >> 10858437

Collagen, convulxin, and thrombin stimulate aggregation-independent tyrosine phosphorylation of CD31 in platelets. Evidence for the involvement of Src family kinases.

M Cicmil1, J M Thomas, T Sage, F A Barry, M Leduc, C Bon, J M Gibbins.   

Abstract

Platelet endothelial cell adhesion molecule-1 (CD31) is a 130-kDa glycoprotein receptor present on the surface of platelets, neutrophils, monocytes, certain T-lymphocytes, and vascular endothelial cells. CD31 is involved in adhesion and signal transduction and is implicated in the regulation of a number of cellular processes. These include transendothelial migration of leukocytes, integrin regulation, and T-cell function, although its function in platelets remains unclear. In this study, we demonstrate the ability of the platelet agonists collagen, convulxin, and thrombin to induce tyrosine phosphorylation of CD31. Furthermore, we show that this event is independent of platelet aggregation and secretion and is accompanied by an increase in surface expression of CD31. A kinase capable of phosphorylating CD31 was detected in CD31 immunoprecipitates, and its activity was increased following activation of platelets. CD31 tyrosine phosphorylation was reduced or abolished by the Src family kinase inhibitor PP2, suggesting a role for these enzymes. In accordance with this, each of the Src family members expressed in platelets, namely Fyn, Lyn, Src, Yes, and Hck, was shown to co-immunoprecipitate with CD31. The involvement of Src family kinases in this process was confirmed through the study of mouse platelets deficient in Fyn.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10858437     DOI: 10.1074/jbc.M003196200

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  16 in total

1.  Immunoreceptor tyrosine-based inhibitory motif (ITIM)-mediated inhibitory signaling is regulated by sequential phosphorylation mediated by distinct nonreceptor tyrosine kinases: a case study involving PECAM-1.

Authors:  Benjamin E Tourdot; Michelle K Brenner; Kathleen C Keough; Trudy Holyst; Peter J Newman; Debra K Newman
Journal:  Biochemistry       Date:  2013-04-03       Impact factor: 3.162

2.  Platelet PECAM-1 inhibits thrombus formation in vivo.

Authors:  Shahrokh Falati; Sonali Patil; Peter L Gross; Michelle Stapleton; Glenn Merrill-Skoloff; Natasha E Barrett; Katherine L Pixton; Harmut Weiler; Brian Cooley; Debra K Newman; Peter J Newman; Barbara C Furie; Bruce Furie; Jonathan M Gibbins
Journal:  Blood       Date:  2005-09-15       Impact factor: 22.113

3.  Lyn and PECAM-1 function as interdependent inhibitors of platelet aggregation.

Authors:  Zhangyin Ming; Yu Hu; Jizhou Xiang; Peter Polewski; Peter J Newman; Debra K Newman
Journal:  Blood       Date:  2011-02-04       Impact factor: 22.113

4.  Distinct and overlapping functional roles of Src family kinases in mouse platelets.

Authors:  S Séverin; C A Nash; J Mori; Y Zhao; C Abram; C A Lowell; Y A Senis; S P Watson
Journal:  J Thromb Haemost       Date:  2012-08       Impact factor: 5.824

5.  Identification of Fer tyrosine kinase localized on microtubules as a platelet endothelial cell adhesion molecule-1 phosphorylating kinase in vascular endothelial cells.

Authors:  Naoko Kogata; Michitaka Masuda; Yuji Kamioka; Akiko Yamagishi; Akira Endo; Masato Okada; Naoki Mochizuki
Journal:  Mol Biol Cell       Date:  2003-06-13       Impact factor: 4.138

6.  Endothelial Src kinase regulates membrane recycling from the lateral border recycling compartment during leukocyte transendothelial migration.

Authors:  Bidisha Dasgupta; William A Muller
Journal:  Eur J Immunol       Date:  2008-12       Impact factor: 5.532

7.  Thymidine phosphorylase participates in platelet signaling and promotes thrombosis.

Authors:  Wei Li; Alba Gigante; Maria-Jesus Perez-Perez; Hong Yue; Michio Hirano; Thomas M McIntyre; Roy L Silverstein
Journal:  Circ Res       Date:  2014-10-06       Impact factor: 17.367

Review 8.  Future innovations in anti-platelet therapies.

Authors:  N E Barrett; L Holbrook; S Jones; W J Kaiser; L A Moraes; R Rana; T Sage; R G Stanley; K L Tucker; B Wright; J M Gibbins
Journal:  Br J Pharmacol       Date:  2008-04-21       Impact factor: 8.739

9.  PECAM-1 expression and activity negatively regulate multiple platelet signaling pathways.

Authors:  Chris I Jones; Stephen F Garner; Leonardo A Moraes; William J Kaiser; Angela Rankin; Willem H Ouwehand; Alison H Goodall; Jonathan M Gibbins
Journal:  FEBS Lett       Date:  2009-10-20       Impact factor: 4.124

10.  Antithrombotic actions of statins involve PECAM-1 signaling.

Authors:  Leonardo A Moraes; Sakthivel Vaiyapuri; Parvathy Sasikumar; Marfoua S Ali; Neline Kriek; Tanya Sage; Jonathan M Gibbins
Journal:  Blood       Date:  2013-09-12       Impact factor: 22.113

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.